Trump's ObamaCare subsidy shutdown could lead to free insurance
If President Donald Trump prevails in shutting down a major "Obamacare" health insurance subsidy, it would have the unintended consequence of making free basic coverage available to more people, and making upper-tier plans more affordable.
FDA approves cancer breakthrough that costs $375,000 per treatment
The U.S. Food and Drug Administration on Wednesday approved Yescarta, a new gene therapy to treat patients with certain types of lymphoma, marking the second approval for this potential breakthrough approach to fighting cancer.
Medicaid costs, enrollments steady after post-ObamaCare surge: Report
Despite ongoing uncertainty regarding the future of Medicaid, enrollment and costs stabilized during fiscal year 2017, according to a new survey.
Surprise! 4 things you didn't know were taxable
Tax season begins in just a few months, which means there's precious little time left to prevent unwelcome tax surprises next April.
Medicare open enrollment: 3 things to consider
How do you choose Parts A (hospitalization), B (medical insurance) and D (prescription drugs)? Should you go with Medicare Advantage (Part C)? Here is what you need to know.
Swiss biotech group Roche sees 5 pct rise in 9-month sales
Swiss biotech company Roche says sales grew 5 percent in the first nine months of the year, crediting new product launches and citing double-digit growth in the pharmaceuticals division in the U.S. market.
FDA approves Gilead cancer gene therapy; price set at $373,000
U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer.
US regulators approve 2nd gene therapy for blood cancer
U.S. regulators have approved a second gene therapy for blood cancer.
Highmark's Allegheny Health Network announces $1B expansion
Highmark Health will spend $1 billion to expand its Allegheny Health Network hospital chain, including a new 160-bed hospital in Pittsburgh's North Hills suburbs, four smaller neighborhood hospitals, and renovations to existing hospitals, the Pittsburgh-based company announced Wednesday.
Ohio launches $8M search for tech-based opioid crisis solution
The state of Ohio launched an $8 million initiative on Wednesday, asking experts for technology-based proposed solutions to the national opioid crisis that has touched scores of families, including that of Columbus mother Jacqueline Lewis, who said solutions can't come too soon.
Toyota recalls some Sienna minivans for shifter defect
Toyota Motor Co. is recalling 347,120 Sienna minivans worldwide because they can shift out of the "park" position and roll away.
Trump slams new bipartisan health care deal: What's in it?
Following negotiations that lasted for more than a month, Sen. Lamar Alexander (R-Tenn.) and Sen. Patty Murray (D-Wash.) have reached a deal to stabilize the insurance markets, just two weeks before the ObamaCare open enrollment period is set to begin.
Anthem will turn to CVS after troubled Express Scripts deal
Anthem has found a new partner to help run prescription drug coverage after the Blue Cross-Blue Shield insurer's rocky relationship with Express Scripts ends.
Ford recalling about 1.3M vehicles for possible door issue
Ford is recalling about 1.3 million 2015-17 F-150 and 2017 Super Duty vehicles in North America because of potential door problems.
U.S. senators reach bipartisan deal on Obamacare, Trump indicates support
Two U.S. senators on Tuesday reached a bipartisan agreement to shore up Obamacare for two years by reviving federal subsidies for health insurers that President Donald Trump planned to scrap, and the president indicated his support for the plan.
Trump signals support for bipartisan deal to fund health care subsidies
Health care subsidies deal
Rand Paul threatens to vote down GOP budget, potentially jeopardizing tax cuts
Sen. Rand Paul (R-Ky.) is on the fence about the costs of the budget proposal and, where it stands now, he may not be able to support the measure, a source familiar with the matter told FOX Business on Tuesday.
Johnson & Johnson tops Street 3Q forecasts, hikes forecast
Johnson & Johnson is reporting third-quarter earnings of $3.76 billion.
UnitedHealth beats 3Q forecasts, helped by Optum growth
UnitedHealth Groups' third-quarter earnings soared 26 percent to beat Wall Street expectations as its growing Optum business segment once again helped the nation's largest health insurer.
Trump declaring state of emergency on opioids an 'excellent thing,' Ron Ferguson says
GoGoMeds.com CEO Ron Ferguson on the fight against America’s opioid crisis.
















